Andreas Persidis

CEO, Biovista Inc.

Dr. Andreas Persidis is the co-founder and CEO of Biovista Inc. In 2015 he was elected President of the Hellenic Alumni Association of the University of Glasgow and is a founder and past President (2010 – 2019) of the Hellenic BioCluster. He is a member of the EU Horizon2020 Expert Advisory Group on Innovation for SMEs, an expert reviewer and evaluator for the European Commission, the Austrian (FIT-IT) and Greek government, has managed on behalf of the European Commission a roadmap study on systematic innovation, and has advised the Greek government (GSRT) on innovation strategy and research priorities in the areas of IT and the life sciences. Prior to Biovista, Dr. Persidis managed technology development teams at European corporations in the engineering, software and telecoms fields. Dr. Persidis has conducted research in the fields of machine learning and applied Artificial Intelligence. He has published extensively in international journals, co-authored book chapters in systematic drug repositioning and is an invited speaker at forums on drug repositioning, innovation and export oriented high-tech companies. Dr. Persidis publishes on the latest issues relating to AI at his substack at https://dialogueisgood.substack.com